FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972107383> ?p ?o ?g. }

• W1972107383 endingPage "52" @default.
• W1972107383 startingPage "48" @default.
• W1972107383 abstract "Objective. The aim of this study was to study the combination of intraperitoneal α-interferon and cisplatin administered second-line in an alternating sequence in small volume residual epithelial ovarian cancer after second-look surgery and the activity of this combination based on prior response to first-line platinum compounds. Methods. Sixty-two patients with minimal residual (<0.5 cm) epithelial ovarian cancer at reassessment laparotomy were entered into a multicenter trial of intraperitoneal α-interferon alternating with cisplatin given for eight cycles unless disease progression or unacceptable toxicity occurred. The patients were considered favorable if they were platinum-sensitive and/or relapsed 6 months or longer after completing treatment. Another reassessment laparotomy was performed within 12 weeks of completion of treatment in patients who were in clinical remission. Results. Fifty-four patients were clinically evaluable and 18 were surgically reassessed, 5 of whom had a negative reassessment operation (20% complete response and 8% partial response). Of the 54 patients evaluable for toxicity, the most common adverse effects of more than grade 2 were gastrointestinal in 13 (47%), neutropenia in 9 (17%), and leukopenia in 6 (12%). Grade 4 toxicity was seen in 10 instances: 4 gastrointestinal, 2 neutropenia, 2 thrombocytopenia, 1 wound infection, and 1 allergic reaction. Conclusions. α-Interferon and cisplatin are active agents in favorable patients with minimal residual epithelial ovarian cancer at second-look. The combination of the two drugs administered in an alternating sequence appears to be associated with more side effects than when either drug is administered alone. The combination produced response rates similar to those seen when either drug is given alone." @default.
• W1972107383 created "2016-06-24" @default.
• W1972107383 creator A5012517342 @default.
• W1972107383 creator A5031844208 @default.
• W1972107383 creator A5040289912 @default.
• W1972107383 creator A5046069358 @default.
• W1972107383 creator A5053891169 @default.
• W1972107383 creator A5071052216 @default.
• W1972107383 creator A5088745795 @default.
• W1972107383 date "1999-07-01" @default.
• W1972107383 modified "2023-09-27" @default.
• W1972107383 title "Intraperitoneal α-Interferon Alternating with Cisplatin in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group Study" @default.
• W1972107383 cites W1967864609 @default.
• W1972107383 cites W1982270480 @default.
• W1972107383 cites W2004121163 @default.
• W1972107383 cites W2010954378 @default.
• W1972107383 cites W2084500050 @default.
• W1972107383 cites W2098863590 @default.
• W1972107383 cites W2109522166 @default.
• W1972107383 cites W2111636750 @default.
• W1972107383 cites W2241933379 @default.
• W1972107383 cites W2316501478 @default.
• W1972107383 cites W2411633317 @default.
• W1972107383 doi "https://doi.org/10.1006/gyno.1999.5455" @default.
• W1972107383 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10385550" @default.
• W1972107383 hasPublicationYear "1999" @default.
• W1972107383 type Work @default.
• W1972107383 sameAs 1972107383 @default.
• W1972107383 citedByCount "32" @default.
• W1972107383 countsByYear W19721073832012 @default.
• W1972107383 countsByYear W19721073832014 @default.
• W1972107383 countsByYear W19721073832015 @default.
• W1972107383 countsByYear W19721073832020 @default.
• W1972107383 countsByYear W19721073832021 @default.
• W1972107383 countsByYear W19721073832022 @default.
• W1972107383 crossrefType "journal-article" @default.
• W1972107383 hasAuthorship W1972107383A5012517342 @default.
• W1972107383 hasAuthorship W1972107383A5031844208 @default.
• W1972107383 hasAuthorship W1972107383A5040289912 @default.
• W1972107383 hasAuthorship W1972107383A5046069358 @default.
• W1972107383 hasAuthorship W1972107383A5053891169 @default.
• W1972107383 hasAuthorship W1972107383A5071052216 @default.
• W1972107383 hasAuthorship W1972107383A5088745795 @default.
• W1972107383 hasConcept C121608353 @default.
• W1972107383 hasConcept C126322002 @default.
• W1972107383 hasConcept C141071460 @default.
• W1972107383 hasConcept C143998085 @default.
• W1972107383 hasConcept C197934379 @default.
• W1972107383 hasConcept C2776694085 @default.
• W1972107383 hasConcept C2777063308 @default.
• W1972107383 hasConcept C2777088508 @default.
• W1972107383 hasConcept C2778239845 @default.
• W1972107383 hasConcept C2778461978 @default.
• W1972107383 hasConcept C2779823535 @default.
• W1972107383 hasConcept C2780427987 @default.
• W1972107383 hasConcept C2780435969 @default.
• W1972107383 hasConcept C2780778865 @default.
• W1972107383 hasConcept C2780873365 @default.
• W1972107383 hasConcept C29730261 @default.
• W1972107383 hasConcept C3019054536 @default.
• W1972107383 hasConcept C71924100 @default.
• W1972107383 hasConcept C90924648 @default.
• W1972107383 hasConceptScore W1972107383C121608353 @default.
• W1972107383 hasConceptScore W1972107383C126322002 @default.
• W1972107383 hasConceptScore W1972107383C141071460 @default.
• W1972107383 hasConceptScore W1972107383C143998085 @default.
• W1972107383 hasConceptScore W1972107383C197934379 @default.
• W1972107383 hasConceptScore W1972107383C2776694085 @default.
• W1972107383 hasConceptScore W1972107383C2777063308 @default.
• W1972107383 hasConceptScore W1972107383C2777088508 @default.
• W1972107383 hasConceptScore W1972107383C2778239845 @default.
• W1972107383 hasConceptScore W1972107383C2778461978 @default.
• W1972107383 hasConceptScore W1972107383C2779823535 @default.
• W1972107383 hasConceptScore W1972107383C2780427987 @default.
• W1972107383 hasConceptScore W1972107383C2780435969 @default.
• W1972107383 hasConceptScore W1972107383C2780778865 @default.
• W1972107383 hasConceptScore W1972107383C2780873365 @default.
• W1972107383 hasConceptScore W1972107383C29730261 @default.
• W1972107383 hasConceptScore W1972107383C3019054536 @default.
• W1972107383 hasConceptScore W1972107383C71924100 @default.
• W1972107383 hasConceptScore W1972107383C90924648 @default.
• W1972107383 hasIssue "1" @default.
• W1972107383 hasLocation W19721073831 @default.
• W1972107383 hasLocation W19721073832 @default.
• W1972107383 hasOpenAccess W1972107383 @default.
• W1972107383 hasPrimaryLocation W19721073831 @default.
• W1972107383 hasRelatedWork W1968920259 @default.
• W1972107383 hasRelatedWork W1972107383 @default.
• W1972107383 hasRelatedWork W2029708816 @default.
• W1972107383 hasRelatedWork W2062361633 @default.
• W1972107383 hasRelatedWork W2066672242 @default.
• W1972107383 hasRelatedWork W2364106504 @default.
• W1972107383 hasRelatedWork W2367017737 @default.
• W1972107383 hasRelatedWork W2414573978 @default.
• W1972107383 hasRelatedWork W3193896426 @default.
• W1972107383 hasRelatedWork W363598932 @default.
• W1972107383 hasVolume "74" @default.
• W1972107383 isParatext "false" @default.

• next